跳到內容

腫瘤科(兒科)

血小板減少症的管理

Eltrombopag for secondary failure of platelet recovery post-allogeneic hematopoietic stem cell transplant in children. (開啟新視窗)

Ali S, Gassas A, Kirby-Allen M, Krueger J, Ali M, Schechter T

來源‎: Pediatr Transplant 2017;21(6):e13017.

檢索‎: PubMed 28653480

DOI碼‎: 10.1111/petr.13017

https://www.ncbi.nlm.nih.gov/pubmed/28653480 (開啟新視窗)

Romiplostim for immune thrombocytopenia in neuroblastoma patients receiving chemotherapy. (開啟新視窗)

Fassel H, Bussel JB, Roberts SS, Modak S

來源‎: J Pediatr Hematol Oncol 2019;41(4):e257-9.

檢索‎: PubMed 29683946

DOI碼‎: 10.1097/MPH.0000000000001187

https://www.ncbi.nlm.nih.gov/pubmed/29683946 (開啟新視窗)

Romiplostim for therapy-related thrombocytopenia in pediatric malignancies. (開啟新視窗)

Jacobson AE, Shah N, Setty BA

來源‎: Pediatr Blood Cancer 2017;64(8):e26473.

檢索‎: PubMed 28150377

DOI碼‎: 10.1002/pbc.26473

http://www.ncbi.nlm.nih.gov/pubmed/28150377 (開啟新視窗)

Eltrombopag for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation in children. (開啟新視窗)

Li S, Wu R, Wang B, Fu L, Zhu G, Zhou X, Ma J, Zhang L, Qin M

來源‎: J Pediatr Hematol Oncol 2019;41(1):38-41.

檢索‎: PubMed 30080752

DOI碼‎: 10.1097/MPH.0000000000001263

https://www.ncbi.nlm.nih.gov/pubmed/30080752 (開啟新視窗)

Romiplostim for secondary thrombocytopenia following allogeneic stem cell transplantation in children. (開啟新視窗)

Maximova N, Zanon D, Rovere F, Maestro A, Schillani G, Paparazzo R

來源‎: Int J Hematol 2015;102(5):626-32.

檢索‎: PubMed 26084627

DOI碼‎: 10.1007/s12185-015-1821-1

https://www.ncbi.nlm.nih.gov/pubmed/26084627 (開啟新視窗)

Chemotherapy induced thrombocytopenia in pediatric oncology. (開啟新視窗)

Tamamyan G, Danielyan S, Lambert MP

來源‎: Crit Rev Oncol Hematol 2016;99:299-307.

檢索‎: PubMed 26811139

DOI碼‎: 10.1016/j.critrevonc.2016.01.005

https://www.ncbi.nlm.nih.gov/pubmed/26811139 (開啟新視窗)

Oncological management of pediatric cancer patients belonging to Jehovahs Witnesses: a two-institutional experience report. (開啟新視窗)

Tenenbaum T, Hasan C, Kramm CM, Janssen G, Laws HJ, Wessalowski R, Bode U, Göbel U

來源‎: Onkologie 2004;27(2):131-7.

檢索‎: PubMed 15138344

DOI碼‎: 10.1159/000076901

https://www.ncbi.nlm.nih.gov/pubmed/15138344 (開啟新視窗)

Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience. (開啟新視窗)

Tsimberidou AM, Giles FJ, Khouri I, Bueso-Ramos C, Pilat S, Thomas DA, Cortes J, Kurzrock R.

來源‎: Ann Oncol 2005;16(1):139-45.

檢索‎: PubMed 15598951

DOI碼‎: 10.1093/annonc/mdi007

https://www.ncbi.nlm.nih.gov/pubmed/15598951 (開啟新視窗)

Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. (開啟新視窗)

Wandt H, Frank M, Ehninger G, Schneider C, Brack N, Daoud A, Fackler-Schwalbe I, Fischer J, Gäckle R, Geer T, Harms P, Löffler B, Ohl S, Otremba B, Raab M, Schönrock-Nabulsi P, Strobel G, Winter R, Link H

來源‎: Blood 1998;91(10):3601-6.

檢索‎: PubMed 9572994

https://www.ncbi.nlm.nih.gov/pubmed/9572994 (開啟新視窗)